Plain-English translation of NCT06668792 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This clinical trial is testing a new medication called to see if it can help people whose multiple myeloma (a type of blood cancer) has stopped responding to previous treatments or has come back. The study will enroll about 100 patients and carefully monitor how well the medication works and what side effects it may cause. Researchers want to understand whether this treatment could be a helpful option for people in situations where other therapies have failed.
Multiple myeloma can become resistant to standard treatments over time, leaving patients with limited options. This medication is designed to work in a new way to help people whose cancer has stopped responding to the usual drugs, potentially offering hope when other therapies no longer work.
You likely qualify if…
You likely don't qualify if…
If you enroll, you will receive and visit the clinic regularly so doctors can monitor how you respond and watch for any side effects. The study will measure your cancer using blood tests and imaging to see if the medication is helping. You will be asked to report how you feel and any symptoms you experience throughout your participation.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
Russia